NIAID- VRC- Research, Development, and Production to Support Clinical Trials for HIV Vaccines.

NIAID-VRC-支持 HIV 疫苗临床试验的研究、开发和生产。

• 批准号: 10722425
• 负责人: DAVID LINDSAY
• 金额: $ 1014.32万
• 依托单位: LEIDOS BIOMEDICAL RESEARCH, INC.
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-04-12 至 2027-07-17
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10722425
• 关键词: Biological Assay; Clinic; Clinical Trials; Development; HIV vaccine; Health; Human; Laboratories; Mission; National Institute of Allergy and Infectious Disease; Phase; Production; Research; Testing; Toxicology; United States National Institutes of Health; Vaccine Research; Vaccines; human disease; improved; large scale production; manufacturing process; meetings; research and development; vaccine development

The Dale and Betty Bumpers Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID), at the National Institutes of Health, was established to facilitate research in vaccine development and is dedicated to improving global human health through the rigorous pursuit of effective vaccines and treatments for human diseases. One of the key components of the VRC's mission involves the rapid advancement of promising candidates from the laboratory to the clinic. Meeting this mission necessitates the development and manufacturing of vaccines for toxicology, and Phase 1/11 clinical trials.

国家卫生研究院（Nation of National Institutes of National Institutes of National Institutes of National Institutes of National of Nation and Terrergy and Indectious疾病研究中心（NIAID））的Dale和Betty Bumpers疫苗研究中心（VRC）被建立，以促进疫苗开发的研究，并致力于通过对人类疾病的有效疫苗和治疗方法来改善全球人类健康。 VRC任务的关键组成部分之一是从实验室到诊所的有前途的候选人的快速发展。实现此任务需要开发和制造毒理学疫苗以及1/11阶段的临床试验。